Apigenin induces apoptosis and impairs head and neck carcinomas EGFR/ErbB2 signaling

Frontiers in Bioscience

Volumn 16, Issue 3, 2011, Pages 1060-1068

  Masuelli, Laura ^a   Marzocchella, Laura ^b   Quaranta, Alessandro ^c   Palumbo, Camilla ^b   Pompa, Giorgio ^c   Izzi, Valerio ^b   Canini, Antonella ^b   Modesti, Andrea ^b   Galvano, Fabio ^d   Bei, Roberto ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

Apigenin; ErbB receptors; HNSCCs; Phosphorylation

Indexed keywords

APIGENIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

APOPTOSIS; ARTICLE; CARCINOMA; DRUG EFFECT; HEAD AND NECK TUMOR; HUMAN; PHARYNX CANCER; PHYSIOLOGY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR; TUMOR CELL LINE;

APIGENIN; APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASMS, SQUAMOUS CELL; PHARYNGEAL NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; TONGUE NEOPLASMS;

EID: 79955056640     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3735     Document Type: Article

References (46)

1. S. Shukla, S. Gupta. Apigenin: a promising molecule for cancer prevention. Pharm Res 27, 962-978 (2010)
2. D. Patel, S. Shukla, S. Gupta. Apigenin and cancer chemoprevention: progress, potential and promise (review). Int J Oncol 30, 233-245 (2007)
3. M.B. Ujiki, X.Z. Ding, M.R. Salabat, D.J. Bentrem, L. Golkar, B. Milam, M.S. Talamonti, R.H. Bell Jr, T. Iwamura, T.E. Adrian. Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol Cancer 5, 76 (2006)
4. S. Shukla, S. Gupta. Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: an in vitro and in vivo study. Mol Carcinog 48, 243-252 (2009)
5. S. Shukla, S. Gupta. Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell Cycle 6, 1102-1114 (2007) (Pubitemid 46708584)
6. F. Yin, A.E. Giuliano, R.E. Law, A.J .Van Herle. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Anticancer Res 21(1A), 413-420 (2001) (Pubitemid 32267675)
7. D.M. Lepley, J.C. Pelling. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin. Mol Carcinog 19, 74-82 (1997) (Pubitemid 27296738)
8. T.D. Way, M.C. Kao, J.K. Lin. Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells. FEBS Lett 579, 145-152 (2005)
9. T.D. Way, M.C. Kao, J.K. Lin. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem 279, 4479-4489 (2004)
10. H.F. Lu, Y.J. Chie, M.S. Yang, C.S. Lee, J.J .Fu, J.S. Yang, T.W. Tan, S.H. Wu, Y.S. Ma, S.W. Ip, J.G. Chung. Apigenin induces caspase-dependent apoptosis in human lung cancer A549 cells through Bax- and Bcl-2-triggered mitochondrial pathway. Int J Oncol 36, 1477-1484 (2010)
11. E.J. Choi, G.H. Kim. Apigenin Induces Apoptosis through a Mitochondria/Caspase-Pathway in Human Breast Cancer MDA-MB-453 Cells. J Clin Biochem Nutr 44, 260-265 (2009)
12. E.J. Choi, G.H. Kim. Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells. J Nutr Biochem 20, 285-290 (2009)
13. M.A. Vargo, O.H. Voss, F. Poustka, A.J. Cardounel, E. Grotewold, A.I. Doseff. Apigenin-induced-apoptosis is mediated by the activation of PKCdelta and caspases in leukemia cells. Biochem Pharmacol 72, 681-692 (2006) (Pubitemid 44233544)
14. P.W. Zheng, L.C. Chiang, C.C. Lin. Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells. Life Sci 76, 1367-1379 (2005)
15. F .Yin, A.E. Giuliano, A.J. Van Herle. Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO). Anticancer Res 19(5B), 4297-4303 (1999)
16. S. Gupta, F. Afaq, H. Mukhtar. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene 21, 3727-3738 (2002) (Pubitemid 34620536)
17. C.A. Franzen, E. Amargo, V. Todorović, B.V. Desai, S. Huda, S. Mirzoeva, K. Chiu, B.A. Grzybowski, T.L. Chew, K.J. Green, J.C. Pelling. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism. Cancer Prev Res (Phila Pa) 2, 830-841 (2009)
18. X.W. Hu, D. Meng, J. Fang. Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase. Carcinogenesis 29, 2369-2376 (2008)
19. J. Fang, Q. Zhou, L.Z. Liu, C. Xia, X. Hu, X. Shi, B.H. Jiang. Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression. Carcinogenesis 28, 858-864 (2007) (Pubitemid 46523341)
20. L.Z. Liu, J. Fang, Q. Zhou, X. Hu, X. Shi, B.H. Jiang. Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer. Mol Pharmacol 68, 635-643 (2005) (Pubitemid 41206017)
21. W.J. Lee, W.K. Chen, C.J. Wang, W.L. Lin, T.H. Tseng. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Toxicol Appl Pharmacol 226, 178-191 (2008)
22. S. Caltagirone, C. Rossi, A. Poggi, F.O. Ranelletti, P.G. Natali, M. Brunetti, F.B. Aiello, M. Piantelli. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer 87, 595-600 (2000) (Pubitemid 30639822)
23. A.R. Hussain, A.S. Khan, S.O. Ahmed, M. Ahmed, L.C. Platanias, K.S. Al-Kuraya, S. Uddin. Apigenin induces apoptosis via downregulation of S-phase kinaseassociated protein 2-mediated induction of p27Kip1 in primary effusion lymphoma cells. Cell Prolif 43, 170-183 (2010)
24. S.H. Landis, T. Murray, S. Bolden, P.A. Wingo. Cancer statistics, 1999. CA Cancer J Clin 49, 8-31 (1999) (Pubitemid 29094959)
25. B.J. Braakhuis, C.R. Leemans, R.H. Brakenhoff. A genetic progression model of oral cancer: current evidence and clinical implications. J Oral Pathol Med 33, 317-322 (2004) (Pubitemid 38931752)
26. R. Bei, L. Masuelli, P. Trono, P.L. Orvietani, S. Losito, L. Marzocchella, D. Vitolo, L. Albonici, M.A. Mrozek, E. Di Gennaro, F. Lista, G. Faggioni, F. Ionna, L. Binaglia, V. Manzari, A. Budillon, A. Modesti. The ribosomal P0 protein induces a spontaneous immune response in patients with head and neck advanced stage carcinoma that is not dependent on its overexpression in carcinomas. Int J Oncol 31, 1301-1308 (2007)
27. P. O-charoenrat, P.H. Rhys-Evans, H. Modjtahedi, S.A. Eccles. The role of c-erbB receptors and ligands in head and neck squamous cell carcinoma. Oral Oncol 38, 627-640 (2002) (Pubitemid 34880101)
28. R. Bei, A. Budillon, L. Masuelli, V. Cereda, D. Vitolo, E. Di Gennaro, V. Ripavecchia, C. Palumbo, F. Ionna, S. Losito, A. Modesti, M.H. Kraus, R. Muraro. Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients. J Pathol 204, 317-325 (2004) (Pubitemid 39430092)
29. R. Bei, G. Pompa, D. Vitolo, E. Moriconi, L. Ciocci, M. Quaranta, L. Frati, M.H. Kraus, R. Muraro. Colocalization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma. J Pathol 195, 343-348 (2001)
30. L. Masuelli, C. Focaccetti, V. Cereda, F. Lista, D. Vitolo, P. Trono, P. Gallo, A. Amici, P. Monaci, M. Mattei, M. Modesti, G. Forni, M.H. Kraus, R. Muraro, A. Modesti, R. Bei. Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors. Int J Oncol 30, 381-92 (2007)
31. L. Masuelli, L. Marzocchella, C. Focaccetti, F. Lista, A. Nardi, A. Scardino, M. Mattei, M. Turriziani, M. Modesti, G. Forni, J. Schlom, A. Modesti, R. Bei. Local delivery of recombinant vaccinia virus encoding for neu counteracts growth of mammary tumors more efficiently than systemic delivery in neu transgenic mice. Cancer Immunol Immunother 59, 1247-1258 (2010)
32. L. Masuelli, P. Trono, L. Marzocchella, M.A. Mrozek, C. Palumbo, M. Minieri, F. Carotenuto, R. Fiaccavento, A. Nardi, F. Galvano, P. Di Nardo, A. Modesti, R. Bei. Intercalated disk remodeling in delta-sarcoglycan-deficient hamsters fed with an alpha-linolenic acid-enriched diet. Int J Mol Med 21, 41-48 (2008) (Pubitemid 351222866)
33. R. Bei, L. Masuelli, E. Moriconi, V. Visco, A. Moretti, M.H. Kraus, R. Muraro. Immune responses to all ErbB family receptors detectable in serum of cancer patients. Oncogene 18, 1267-1275 (1999) (Pubitemid 29094878)
34. S.J. Rogers, K.J. Harrington, P. Rhys-Evans, P. OCharoenrat, S.A. Eccles. Biological significance of c-erbB family oncogenes in head and neck cancer. Cancer Metastasis Rev 24, 47-69 (2005) (Pubitemid 40576063)
35. A. Badache, A. Gonçalves. The ErbB2 signaling network as a target for breast cancer therapy. J Mammary Gland Biol Neoplasia 11, 13-25 (2006) (Pubitemid 44309186)
36. M.A. Olayioye, R.M. Neve, H.A. Lane, N.E. Hynes. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19, 3159-3167 (2000) (Pubitemid 30428195)
37. P. Amornphimoltham, V. Sriuranpong, V. Patel, F. Benavides, C.J. Conti, J. Sauk, E.A. Sausville, A.A. Molinolo, J.S. Gutkind. Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01. Clin Cancer Res 10, 4029-4037 (2004) (Pubitemid 38812478)
38. L. Wang, T. Liu, M. Nishioka, R.L. Aguirre, S.S. Win, N. Okada. Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation. Oral Oncol 42, 625-631 (2006) (Pubitemid 43965008)
39. M.G. Hertog, E.J. Feskens, P.C. Hollman, M.B. Katan, D. Kromhout. Dietary flavonoids and cancer risk in the Zutphen Elderly Study. Nutr Cancer 22, 175-184 (1994) (Pubitemid 24310125)
40. J. Peterson, P. Lagiou, E. Samoli, A. Lagiou, K. Katsouyanni, C. La Vecchia, J. Dwyer, D. Trichopoulos. Flavonoid intake and breast cancer risk: a case-control study in Greece. Br J Cancer 89, 1255-1259 (2003) (Pubitemid 37363413)
41. C. Bosetti, L. Spertini, M. Parpinel, P. Gnagnarella, P. Lagiou, E. Negri, S. Franceschi, M. Montella, J. Peterson, J. Dwyer, A. Giacosa, C. La Vecchia. Flavonoids and breast cancer risk in Italy. Cancer Epidemiol Biomarkers Prev 14, 805-808 (2005) (Pubitemid 40478539)
42. S.K. Jaganathan, M. Mandal. Antiproliferative effects of honey and of its polyphenols: a review. J Biomed Biotechnol 2009:830616 (2009)
43. R. Bei, L. Masuelli, M. Turriziani, G. Li Volti, M. Malaguarnera, F. Galvano. Impaired expression and function of signaling pathway enzymes by anthocyanins: role on cancer prevention and progression. Current Enzyme Inhibition 5, 184-197 (2009)
44. S. Gupta, F. Afaq, H. Mukhtar. Selective growthinhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem Biophys Res Commun 287, 914-920 (2001) (Pubitemid 32953563)
45. L.I. Giannola, V. De Caro, G. Giandalia, M.G. Siragusa, C. Paderni, G. Campisi, A.M. Florena. 5- Fluorouracil buccal tablets for locoregional chemotherapy of oral squamous cell carcinoma: formulation, drug release and histological effects on reconstituted human oral epithelium and porcine buccal mucosa. Curr Drug Deliv 7, 109-117 (2010)
46. E.J. Choi, G.H. Kim. 5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells. Oncol Rep 22, 1533-1537 (2009)